• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA head Gottlieb says hurricane damage in Puerto Rico “bad, if not worse” than predicted

FDA head Gottlieb says hurricane damage in Puerto Rico “bad, if not worse” than predicted

September 26, 2017 By Fink Densford

The impact of Hurricane Maria on the island of Puerto Rico, including its substantial medical device manufacturing hub, is “just as bad, if not worse, than predicted,” FDA Commissioner Dr. Scott Gottlieb said in a statement released yesterday.

Many companies are rushing to assess damages to their facilities after the storm, with industry groups like AdvaMed and the FDA undertaking efforts to help begin the process of recovery for not only the production facilities on the island, but the people and infrastructure as well.

At AdvaMed’s Medtech conference today, Gottlieb said that the FDA has been actively engaged in the relief effort for all the damage done by the recent hurricanes, with a specific focus on Maria.

“Over the past week we’ve been especially active with the events unfolding in Puerto Rico. As you know, FDA has a lot of agency personnel on the island. Puerto Rico has long been home to many manufacturing sites of FDA regulated products, including medical devices. The island’s medical product manufacturing base is an important part of its economic foundation, and that industrial base has been a key part in the island’s ongoing economic recovery before this devastating storm,” Gottlieb told the crowd at the MedTech Conference.

Gottlieb said that the FDA is doing everything it can to support both its own personnel and citizens on the island, and that he is planning a personal trip to the island alongside colleagues from the Department of Homeland Security to continue to support such efforts.

AdvaMed chair and CVRx CEO Nadim Yared said the industry group was also working on addressing the issue in Puerto Rico.

“We all watched with alarm and sadness as the Texas gulf coast and my beautiful state of Florida and Puerto Rico and the Caribbeans were all battered by these storms, leaving widespread suffering, loss and destruction in their wake. As a resident of Florida I can tell you there’s nothing to compare to the anxiety and desperation when you are in the path of such a massive, massive force of nature. Our deepest sympathy goes to all those who are feeling the impact of the disaster,” Yared said in a presentation at the MedTech Conference.

Yared said that AdvaMed has partnered with AmeriCares, a health focused humanitarian organization, offering a 2-to-1 donation rate for individuals who ant to donate to the hurricane-affected regions.

Integra LifeSciences (NSDQ:IART), who has facilities on the island, said that its manufacturing facilities in Añasco, Puerto Rico “sustained relatively minor damage from the impact of Hurricane Maria,” and added that a team was on-site to oversee repairs.

The extent of damage to the infrastructure and the impact that will have on the business is less certain, Integra said, though its focus remains on supporting its employees and their families.

The company said it expects to see manufacturing restart in the “next few weeks,” with a gradual ramp in production until operations are restored, and that its inventory levels are “sufficient to mitigate significant sales disruptions,” according to a press release.

Many medtech companies on the island are focused on getting a basic head count of their employees, according to a Star Tribune report.

“Right now, everything is largely about meeting basic human needs. It’s really bad. Communications are almost nonexistant. What the companies are all focused on now is finding their employees, connecting with their employees and communities, and just trying to get a handle on where people are,” Medical Alley Association CEO Shaye Mandle said, according to the paper.

At least 10 deaths have been reported as due ot the storm so far, and the power grid may be inoperable for months, the Star Tribune reported.

The combination of hurricanes Harvey, Irma and Maria are expected to have at least a net 1% impact on US med device revenue for the 3rd quarter, according to a Barclay’s note to investors from analyst Matt Taylor.

Filed Under: Business/Financial News Tagged With: AdvaMed, AdvaMed 2017, Integra LifeSciences

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy